Da Liu
Vorstandsvorsitzender bei CR-CP Life Science Fund
Profil
Da Liu is currently a Non-Executive Director at EyeYon Medical Ltd., a Director at ReViral Ltd., a Director at BELKIN Vision Ltd., a Managing Director at CR-CP Life Science Fund, a Non-Executive Director at Rnaimmune, Inc., and a Non-Executive Director at Mirxes Holding Co., Ltd.
Previously, he was a Director-Strategic Department at China Resources (Holdings) Co., Ltd.
and a Non-Executive Director at Sirnaomics Ltd.
Mr. Liu holds an MBA from Thunderbird School of Global Management and an undergraduate degree from St. John's University.
Aktive Positionen von Da Liu
Unternehmen | Position | Beginn |
---|---|---|
CR-CP Life Science Fund
CR-CP Life Science Fund Investment ManagersFinance CR-CP Life Science Fund is a venture capital fund invests companies located in China. It targets companies operating in the fields of diagnose, medical equipment and health technology. | Vorstandsvorsitzender | 01.12.2019 |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | - |
BELKIN Vision Ltd.
BELKIN Vision Ltd. Medical/Nursing ServicesHealth Services BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel. | Direktor/Vorstandsmitglied | 01.05.2019 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | 18.08.2021 |
EyeYon Medical Ltd.
EyeYon Medical Ltd. Medical SpecialtiesHealth Technology EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 01.02.2021 |
Rnaimmune, Inc.
Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | 01.03.2021 |
Ehemalige bekannte Positionen von Da Liu
Unternehmen | Position | Ende |
---|---|---|
SIRNAOMICS LTD. | Direktor/Vorstandsmitglied | 30.09.2022 |
China Resources (Holdings) Co., Ltd.
China Resources (Holdings) Co., Ltd. Food: Major DiversifiedConsumer Non-Durables China Resources (Holdings) Co., Ltd. develops and manages real estate properties. It also engages in manufacture and distribution of daily consumer goods, properties and related industries, infrastructure and public utilities and pharmaceutical production and distribution services. The company was founded in 1983 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01.12.2019 |
Ausbildung von Da Liu
Thunderbird School of Global Management | Masters Business Admin |
St. John's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SIRNAOMICS LTD. | Health Technology |
Private Unternehmen | 7 |
---|---|
China Resources (Holdings) Co., Ltd.
China Resources (Holdings) Co., Ltd. Food: Major DiversifiedConsumer Non-Durables China Resources (Holdings) Co., Ltd. develops and manages real estate properties. It also engages in manufacture and distribution of daily consumer goods, properties and related industries, infrastructure and public utilities and pharmaceutical production and distribution services. The company was founded in 1983 and is headquartered in Hong Kong. | Consumer Non-Durables |
EyeYon Medical Ltd.
EyeYon Medical Ltd. Medical SpecialtiesHealth Technology EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel. | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
BELKIN Vision Ltd.
BELKIN Vision Ltd. Medical/Nursing ServicesHealth Services BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel. | Health Services |
CR-CP Life Science Fund
CR-CP Life Science Fund Investment ManagersFinance CR-CP Life Science Fund is a venture capital fund invests companies located in China. It targets companies operating in the fields of diagnose, medical equipment and health technology. | Finance |
Rnaimmune, Inc.
Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Health Technology |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Finance |